PositiveDouble Blind Clinical Trial2023
Trial of a Novel Oral Cannabinoid Formulation in Patients with Hypertension: A Double-Blind, Placebo-Controlled Pharmacogenetic Study
Classification Results
AI Classification
PositiveFine-tuned Classification
Positive